Brief: DICE Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results
March 21 (Reuters) - DICE Therapeutics Inc DICE.O :
* DICE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND RECENT HIGHLIGHTS
* DICE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.44
Source text for Eikon: ID:nGNX8kgyYL
Further company coverage: DICE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dice Therapeutics
See all newsBrief: Lilly Completes Acquisition Of Dice Therapeutics
Dice Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Eli Lilly Announces Extension Of Tender Offer To Acquire Dice
MoonLake Immunotherapeutics explores sale-sources
MoonLake Immunotherapeutics explores sale-sources